Our bioinformation analysis data shows that ZGRF1 expression also positively correlates with the mRNA levels of BRCA1 and EXO1, which are well known for PARPi targets, and higher expression of ZGRF1 predicts poor prognosis of patients in several types of cancer. Here, EXO1 is linked to cancer.